Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

KRAS mutation is associated with elevated myeloblastin activity in human lung adenocarcinoma.

Cancer genomics & proteomics - 1 Jan 2012

Wiedl Thomas, Collaud Stéphane, Hillinger Sven, Arni Stephan, Burgess Chris, Kroll Werner, Schraml Peter, Soltermann Alex, Moch Holger, Weder Walter

Abstract excerpt

Lung cancer is the leading cause of all cancer deaths worldwide with suboptimal prognosis and treatment options. Therefore this study aimed to identify molecular characteristics with a predictive clinical utility which at the same time might represent novel therapeutic targets for human lung adenocarcinoma. Within this study mutations of v-Ki-RAS2 Kirsten rat sarcoma viral oncogene homolog (KRAS), a gene...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma
Share to Enzyme Activation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gene Expression Regulation, Neoplastic

Share to Lung Neoplasms

Share to Neoplasm Staging

Share to Proto-Oncogene Proteins

Share to Proto-Oncogene Proteins p21(ras)

Share to ras Proteins

Source

Identifiers

PMID: 22210048

Genes

KRAS

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

KRAS mutation is associated with elevated myeloblastin activity in human lung adenocarcinoma.PMID 22210048Read ↗

Proteogenomic characterization reveals tumorigenesis and progression of lung cancer manifested as subsolid nodulesSemantic proximity Read ↗

Lung cancer molecular mutations and abnormal glycosylation as biomarkers for early diagnosis.Semantic proximity Read ↗

Carboxypeptidase N2 as a Novel Diagnostic and Prognostic Biomarker for Lung AdenocarcinomaSemantic proximity Read ↗

Multiscale profiling of enzyme activity in cancerSemantic proximity Read ↗

Mutant KRAS-Associated Proteome Is Mainly Controlled by Exogenous Factors.Semantic proximity Read ↗

Metabolic rewiring in mutant Kras lung cancer.Semantic proximity Read ↗

Enzyme activity profiles of the secreted and membrane proteome that depict cancer cell invasivenessSemantic proximity Read ↗

Noninvasive lung cancer detection via pulmonary protease profilingSemantic proximity Read ↗

Understanding fibroblast activation protein (FAP): Substrates, activities, expression and targeting for cancer therapySemantic proximity Read ↗

Mutant p53 proteins alter cancer cell secretome and tumour microenvironment: Involvement in cancer invasion and metastasis.Semantic proximity Read ↗

The Serpin Superfamily and Their Role in the Regulation and Dysfunction of Serine Protease Activity in COPD and Other Chronic Lung DiseasesSemantic proximity Read ↗

Proteomic identification of the oncoprotein STAT3 as a target of a novel Skp1 inhibitorSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.